Vascular Procedures

  • Leanne Groban
  • Sylvia Y. Dolinski


Anesthesia for vascular surgery is predominantly geriatric anesthesia. Atherosclerosis, the underlying disease process in the patient with peripheral vascular disease, has an insidious onset but typically presents about 10 years after the diagnosis of coronary artery disease. Given that persons aged 65 years and older comprise the fastestgrowing segment of the United States population, the prevalence of vascular interventions, including minimally invasive angioplasty, endovascular stents, and open reconstructive procedures, will undoubtedly increase. This chapter focuses on anesthetic management for the geriatric patient undergoing aortic and peripheral vascular surgery. Preoperative preparation is a key feature, because various comorbidities associated with advanced age, such as ischemic heart disease, renal insufficiency, and diabetes are robust predictors of cardiac complications in the vascular patient.1 A brief discussion of postoperative care follows the discussion of surgical procedures.


Abdominal Aortic Aneurysm Carotid Endarterectomy Postoperative Delirium Noncardiac Surgery Abdominal Aortic Aneurysm Repair 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043–1049.PubMedGoogle Scholar
  2. 2.
    Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med 2000;160: 2717–2728.PubMedCrossRefGoogle Scholar
  3. 3.
    Fleisher LA. Preoperative cardiac evaluation. Anesthesiol Clin North Am 2004;22:59–75.CrossRefGoogle Scholar
  4. 4.
    Golden MA, Whittemore AD, Donaldson MC, et al. Selective evaluation and management of coronary artery disease in patients undergoing repair of abdominal aortic aneurysms. A 16-year experience. Ann Surg 1990;212:415–420; discussion 420–423.PubMedCrossRefGoogle Scholar
  5. 5.
    Grayburn PA, Hillis LD. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 2003;138:506–511.PubMedGoogle Scholar
  6. 6.
    Eagle KA, Berger PB, Calkins H, et al. American College of Cardiology; American Heart Association. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. J Am Coll Cardiol 2002;39:542–553.PubMedCrossRefGoogle Scholar
  7. 7.
    Studenski S. Exercise. In: Landefeld CS, Palmer RM, Johnson MAG, et al., eds. Current Geriatric Diagnosis and Treatment. New York: McGraw Hill; 2004:441.Google Scholar
  8. 8.
    Lette J, Waters D, Lassonde J, et al. Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg 1991;14:160–169.PubMedCrossRefGoogle Scholar
  9. 9.
    Auerbach AD, Goldman L. ß-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002;287:1435–1444.PubMedCrossRefGoogle Scholar
  10. 10.
    Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742–752.PubMedCrossRefGoogle Scholar
  11. 11.
    Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335: 1713–1720.PubMedCrossRefGoogle Scholar
  12. 12.
    Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789–1794.PubMedCrossRefGoogle Scholar
  13. 13.
    Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999;88:477–482.PubMedCrossRefGoogle Scholar
  14. 14.
    Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998;88:7–17.PubMedCrossRefGoogle Scholar
  15. 15.
    Boersma E, Poldermans D, Bax JJ, et al. DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography). Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001;285:1865–1873.PubMedCrossRefGoogle Scholar
  16. 16.
    Poldermans D, Boersma E, Bax JJ, et al. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001;22:1353–1358.PubMedCrossRefGoogle Scholar
  17. 17.
    Landesberg G. The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothorac Vasc Anesth 2003;17:90–100.PubMedCrossRefGoogle Scholar
  18. 18.
    Warltier DC. Beta-adrenergic-blocking drugs: incredibly useful, incredibly underutilized. Anesthesiology 1998;88: 2–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Mendelson G, Aronow WS. Underutilization of betablockers in older patients with prior myocardial infarction or coronary artery disease in an academic, hospital-based geriatrics practice. J Am Geriatr Soc 1997;45:1360–1361.PubMedGoogle Scholar
  20. 20.
    Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115–121.PubMedCrossRefGoogle Scholar
  21. 21.
    Sirak TE, Jelic S, Le Jemtel TH. Therapeutic update: nonselective beta-and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2004;44:497–502.PubMedCrossRefGoogle Scholar
  22. 22.
    Di Bari M, Marchionni N, Pahor M. Beta-blockers after acute myocardial infarction in elderly patients with diabetes mellitus: time to reassess. Drugs Aging 2003;20:13–22.PubMedCrossRefGoogle Scholar
  23. 23.
    Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999;91:1674–1686.PubMedCrossRefGoogle Scholar
  24. 24.
    [No authors listed.] Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001–2007.CrossRefGoogle Scholar
  25. 25.
    Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive HeartFailure (MERIT-HF). MERIT-HFStudy Group. JAMA 2000;283:1295–1302.PubMedCrossRefGoogle Scholar
  26. 26.
    Deedwania PC, Gottlieb S, Ghali JK, et al. MERIT-HF Study Group. Efficacy, safety and tolerability of betaadrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 2004;25: 1300–1309.PubMedCrossRefGoogle Scholar
  27. 27.
    Ebert TJ, Morgan BJ, Barney JA, et al. Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol 1992;263:H798–803.PubMedGoogle Scholar
  28. 28.
    Wallace AW, Galindez D, Salahieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 2004;101:284–293.PubMedCrossRefGoogle Scholar
  29. 29.
    Oliver MF, Goldman L, Julian DG, et al. Effect of mivazerol on perioperative cardiac complications during noncardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 1999; 91:951–961.PubMedCrossRefGoogle Scholar
  30. 30.
    Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 1997;86:331–345.PubMedCrossRefGoogle Scholar
  31. 31.
    Boldt J, Rothe G, Schindler E, et al. Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery? Heart 1996;76: 127–213.CrossRefGoogle Scholar
  32. 32.
    Myles PS, Hunt JO, Holdgaard HO, et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care 1999;27:137–147.PubMedGoogle Scholar
  33. 33.
    Undas A, Brozek J, Musial J. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease. Clin Lab 2002;48:287–296.PubMedGoogle Scholar
  34. 34.
    Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002;105: 868–873.PubMedCrossRefGoogle Scholar
  35. 35.
    Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129–1135.PubMedGoogle Scholar
  36. 36.
    Hasegawa H, Yamamoto R, Takano H, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. J Mol Cell Cardiol 2003;35:953–960.PubMedCrossRefGoogle Scholar
  37. 37.
    Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107:1848–1851.PubMedCrossRefGoogle Scholar
  38. 38.
    Kertai MD, Boersma E, Westerhout CM, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 2004;116: 96–103.PubMedCrossRefGoogle Scholar
  39. 39.
    O’Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005;45:336–342.PubMedCrossRefGoogle Scholar
  40. 40.
    Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004;291:2092–2099.PubMedCrossRefGoogle Scholar
  41. 41.
    Stone NJ. Are statins indicated for the primary prevention of coronary heart disease in octogenarians? Protagonist viewpoint. Am J Geriatr Cardiol 2003;12:351–356.PubMedCrossRefGoogle Scholar
  42. 42.
    Foody JM, Krumholz HM. Are statins indicated for the primary prevention of CAD in octogenarians? Antagonist viewpoint. Am J Geriatr Cardiol 2003;12:357–360.PubMedCrossRefGoogle Scholar
  43. 43.
    Alter DA, Manuel DG, Gunraj N, et al. Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies. Am J Med 2004;116:540–545.PubMedCrossRefGoogle Scholar
  44. 44.
    Shepherd J, Blauw GJ, Murphy MB, et al. PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623–1630.PubMedCrossRefGoogle Scholar
  45. 45.
    McGowan MP. Treating to New Target (TNT) Study Group. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 2004;110: 2333–2335.PubMedCrossRefGoogle Scholar
  46. 46.
    Liu LL, Dzankic S, Leung JM. Preoperative electrocardiogram abnormalities do not predict postoperative cardiac complications in geriatric surgical patients. J Am Geriatr Soc 2002;50:1186–1191.PubMedCrossRefGoogle Scholar
  47. 47.
    Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288–1294.PubMedCrossRefGoogle Scholar
  48. 48.
    Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999;89:553–560.PubMedCrossRefGoogle Scholar
  49. 49.
    Maisel AS. The diagnosis of acute congestive heart failure: role of BNP measurements. Heart Fail Rev 2003;8: 327–334.PubMedCrossRefGoogle Scholar
  50. 50.
    Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710–1718.PubMedCrossRefGoogle Scholar
  51. 51.
    Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide in an elderly population. J Intern Med 1997;242: 307–311.PubMedCrossRefGoogle Scholar
  52. 52.
    Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105:1387–1393.PubMedCrossRefGoogle Scholar
  53. 53.
    Groban L. Diastolic dysfunction in the older heart: a review. J Cardiothorac Vasc Anesth 2005;19:228–236.PubMedCrossRefGoogle Scholar
  54. 54.
    Somes GW, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999;159:2004–2009.PubMedCrossRefGoogle Scholar
  55. 55.
    Mitchell GF, Parise H, Benjamin EJ, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004;43:1239–1245.PubMedCrossRefGoogle Scholar
  56. 56.
    Pauca AL, Kon ND, O’Rourke MF. The second peak of the radial artery pressure wave represents aortic systolic pressure in hypertensive and elderly patients. Br J Anaesth 2004;92:651–657.PubMedCrossRefGoogle Scholar
  57. 57.
    London GM. Large artery function and alterations in hypertension. J Hypertens Suppl 1995;13:S35–38.PubMedCrossRefGoogle Scholar
  58. 58.
    Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995;82:1026–1060.PubMedCrossRefGoogle Scholar
  59. 59.
    Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869–874.PubMedGoogle Scholar
  60. 60.
    Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000;85:251–255.PubMedCrossRefGoogle Scholar
  61. 61.
    Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865–872.PubMedCrossRefGoogle Scholar
  62. 62.
    Vaccarino V, Berger AK, Abramson J, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 2001; 88: 980–986.PubMedCrossRefGoogle Scholar
  63. 63.
    Shammash JB, Trost JC, Gold J, et al. Perioperative betablocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001;141:148–153.PubMedCrossRefGoogle Scholar
  64. 64.
    Comfere T, Sprung J, Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005;100:636–644.PubMedCrossRefGoogle Scholar
  65. 65.
    Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997;84:945–949.PubMedCrossRefGoogle Scholar
  66. 66.
    Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994;81:299–307.PubMedCrossRefGoogle Scholar
  67. 67.
    Bertrand M, Godet G, Meersschaert K, et al. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001;92:26–30.PubMedCrossRefGoogle Scholar
  68. 68.
    Prys-Roberts C. Hypertension and anesthesia—fifty years on. Anesthesiology 1979;50:281–284.PubMedCrossRefGoogle Scholar
  69. 69.
    Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979;50:285–292.PubMedCrossRefGoogle Scholar
  70. 70.
    Howell SJ, Hemming AE, Allman KG, et al. Predictors of postoperative myocardial ischaemia. The role of intercurrent arterial hypertension and other cardiovascular risk factors. Anaesthesia 1997;52:107–111.PubMedCrossRefGoogle Scholar
  71. 71.
    Arozullah AM, Khuri SF, Henderson WG, et al. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001;135:847–857.PubMedGoogle Scholar
  72. 72.
    Hall JC, Tarala RA, Hall JL, et al. A multivariate analysis of the risk of pulmonary complications after laparotomy. Chest 1991;99:923–927.PubMedCrossRefGoogle Scholar
  73. 73.
    Swaminathan M, Stafford-Smith M. Renal dysfunction after vascular surgery. Curr Opin Anaesthesiol 2003;16:45–51.PubMedCrossRefGoogle Scholar
  74. 74.
    Sadovnikoff N, Gelman S. Perioperative renal protection. Curr Opin Anaesthesiol 1999;12:337–341.PubMedCrossRefGoogle Scholar
  75. 75.
    Tiggeler RG, Berden JH, Hoitsma AJ, et al. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 1985;201:246–251.PubMedCrossRefGoogle Scholar
  76. 76.
    Nicholson ML, Baker DM, Hopkinson BR, et al. Randomized controlled trial of the effect of mannitol on renal reperfusion injury during aortic aneurysm surgery. Br J Surg 1996;83:1230–1233.PubMedCrossRefGoogle Scholar
  77. 77.
    Gelman S. Renal protection during surgical stress. Acta Anaesthesiol Scand Suppl 1997;110:43–45.PubMedGoogle Scholar
  78. 78.
    Phillip B, Pastor D, Bellows W, et al. The prevalence of preoperative diastolic filling abnormalities in geriatric surgical patients. Anesth Analg 2003;97:1214–1221.PubMedCrossRefGoogle Scholar
  79. 79.
    Gilbert TB, Hasnain JU, Flinn WR, et al. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair. J Cardiovasc Pharmacol Ther 2001;6:31–36.PubMedCrossRefGoogle Scholar
  80. 80.
    Halpenny M, Rushe C, Breen P, et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002;19:32–39.PubMedCrossRefGoogle Scholar
  81. 81.
    Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857–861.PubMedCrossRefGoogle Scholar
  82. 82.
    Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997;277:1127–1134.PubMedCrossRefGoogle Scholar
  83. 83.
    Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996;334:1209–1215.PubMedCrossRefGoogle Scholar
  84. 84.
    Gold MR, Dec GW, Cocca-Spofford D, et al. Esmolol and ventilatory function in cardiac patients with COPD. Chest 1991;100:1215–1218.PubMedCrossRefGoogle Scholar
  85. 85.
    Roy RC. What’s New in Geriatric Anesthesia? 55th Annual Refresher Course Lectures and Basic Science Reviews. Park Ridge, IL: American Society of Anesthesiologists; 2004:109.Google Scholar
  86. 86.
    Benumof JL. Preoxygenation: best method for both efficacy and efficiency. Anesthesiology 1999;91:603–605.PubMedCrossRefGoogle Scholar
  87. 87.
    Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Aprospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997;41:1095–1103.PubMedCrossRefGoogle Scholar
  88. 88.
    Moore EW, Hunter JM. The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth 2001; 87:912–925.PubMedCrossRefGoogle Scholar
  89. 89.
    Arain SR, Ruehlow RM, Uhrich TD, et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 2004;98:153–158.PubMedCrossRefGoogle Scholar
  90. 90.
    Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidinebased versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003;17:576–584.PubMedCrossRefGoogle Scholar
  91. 91.
    Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 2000;90:834–839.PubMedCrossRefGoogle Scholar
  92. 92.
    Cook DJ, Rooke G A. Priorities in perioperative geriatrics. Anesth Analg 2003;96:1823–1836.PubMedCrossRefGoogle Scholar
  93. 93.
    Rosenfeld BA, Beattie C, Christopherson R, et al. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993;79:435–443.PubMedCrossRefGoogle Scholar
  94. 94.
    Norris EJ, Beattie C, Perler BA, et al. Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology 2001;95:1054–1067.PubMedCrossRefGoogle Scholar
  95. 95.
    Roy RC. Choosing general versus regional anesthesia for the elderly. Anesthesiol Clin North Am 2000;18: 91–104.CrossRefGoogle Scholar
  96. 96.
    Park WY, Thompson JS, Lee KK. Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg 2001;234:560–569; discussion 569–571.PubMedCrossRefGoogle Scholar
  97. 97.
    Hodgson PS, Liu SS, Gras TW. Does epidural anesthesia have general anesthetic effects? A prospective, randomized, double-blind, placebo-controlled trial. Anesthesiology 1999;91:1687–1692.PubMedCrossRefGoogle Scholar
  98. 98.
    Inagaki Y, Mashimo T, Kuzukawa A, et al. Epidural lidocaine delays arousal from isoflurane anesthesia. Anesth Analg 1994;79:368–372.PubMedCrossRefGoogle Scholar
  99. 99.
    Ishiyama T, Kashimoto S, Oguchi T, et al. Epidural ropivacaine anesthesia decreases the bispectral index during the awake phase and sevoflurane general anesthesia. Anesth Analg 2005;100:728–732.PubMedCrossRefGoogle Scholar
  100. 100.
    Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28:172–197.PubMedCrossRefGoogle Scholar
  101. 101.
    Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000;321:1493.PubMedCrossRefGoogle Scholar
  102. 102.
    Siguret V, Pautas E, Gouin I. Low molecular weight heparin treatment in elderly subjects with or without renal insufficiency: new insights between June 2002 and March 2004. Curr Opin Pulm Med 2004;10:366–370.PubMedCrossRefGoogle Scholar
  103. 103.
    Weller RS, Gerancher JC, Crews JC, et al. Extensive retroperitoneal hematoma without neurologic deficit in two patients who underwent lumbar plexus block and were later anticoagulated. Anesthesiology 2003;98:581–585.PubMedCrossRefGoogle Scholar
  104. 104.
    Dardik A, Lin JW, Gordon TA, et al. Results of elective abdominal aortic aneurysm repair in the 1990s: a population-based analysis of 2335 cases. J Vasc Surg 1999;30: 985–995.PubMedCrossRefGoogle Scholar
  105. 105.
    Sicard GA, Rubin BG, Sanchez LA, et al. Endoluminal graft repair for abdominal aortic aneurysms in high-risk patients and octogenarians: is it better than open repair? Ann Surg 2001;234:427–435; discussion 435–437.PubMedCrossRefGoogle Scholar
  106. 106.
    Lobato AC, Rodriguez-Lopez J, Malik A, et al. Impact of endovascular repair for abdominal aortic aneurysms in octogenarians. Ann Vasc Surg 2001;15:525–532.PubMedCrossRefGoogle Scholar
  107. 107.
    Minor ME, Ellozy S, Carroccio A, et al. Endovascular aortic aneurysm repair in the octogenarian: is it worthwhile? Arch Surg 2004;139:308–314.PubMedCrossRefGoogle Scholar
  108. 108.
    Al-Omran M, Verma S, Lindsay TF, et al. Clinical decision making for endovascular repair of abdominal aortic aneurysm. Circulation 2004;110:e517–523.PubMedCrossRefGoogle Scholar
  109. 109.
    Brinkman WT, Terramani TT, Najibi S, et al. Endovascular abdominal aortic aneurysm repair in the octogenarian. Ann Vasc Surg 2004;18:401–407.PubMedCrossRefGoogle Scholar
  110. 110.
    Biebl M, Lau LL, Hakaim AG, et al. Midterm outcome of endovascular abdominal aortic aneurysm repair in octogenarians: a single institution’s experience. J Vasc Surg 2004;40:435–442.PubMedCrossRefGoogle Scholar
  111. 111.
    Chaikof EL, Blankensteijn JD, Harris PL, et al. Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/ American Association for Vascular Surgery. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002;35:1048–1060.PubMedCrossRefGoogle Scholar
  112. 112.
    Kahn RA, Moskowitz DM, Marin M, et al. Anesthetic considerations for endovascular aortic repair. Mt Sinai J Med 2002;69:57–67.PubMedGoogle Scholar
  113. 113.
    Teufelsbauer H, Prusa AM, Wolff K, et al. Endovascular stent grafting versus open surgical operation in patients with infrarenal aortic aneurysms: a propensity scoreadjusted analysis. Circulation 2002;106:782–787.PubMedCrossRefGoogle Scholar
  114. 114.
    European Carotid Surgery Trialists’ Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991;337:1235–1243.CrossRefGoogle Scholar
  115. 115.
    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–453.Google Scholar
  116. 116.
    Rerkasem K, Bond R, Rothwell PM. Local versus general anaesthesia for carotid endarterectomy. Cochrane Database Syst Rev 2004;(2):CD000126.PubMedGoogle Scholar
  117. 117.
    Groban L, Deal DD, Vernon JC, et al. Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesth Analg 2001;92:37–43.PubMedCrossRefGoogle Scholar
  118. 118.
    Ackerstaff RG, van de Vlasakker CJ. Monitoring of brain function during carotid endarterectomy: an analysis of contemporary methods. J Cardiothorac Vasc Anesth 1998; 12:341–347.PubMedCrossRefGoogle Scholar
  119. 119.
    Stoughton J, Nath RL, Abbott WM. Comparison of simultaneous electroencephalographic and mental status monitoring during carotid endarterectomy with regional anesthesia. J Vasc Surg 1998;28:1014–1021; discussion 1021–1023.PubMedCrossRefGoogle Scholar
  120. 120.
    Wholey MH, Wholey M. Current status in cervical carotid artery stent placement. J Cardiovasc Surg (Torino) 2003;44: 331–339.Google Scholar
  121. 121.
    Mozes G, Sullivan TM, Torres-Russotto DR, et al. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg 2004;39:958–966.PubMedCrossRefGoogle Scholar
  122. 122.
    Bettmann MA, Dake MD, Hopkins LN, et al. American Heart Association. Atherosclerotic Vascular Disease Conference: Writing Group VI: revascularization. Circulation 2004;109:2643–2650.PubMedCrossRefGoogle Scholar
  123. 123.
    Coward LJ, Featherstone RL, Brown MM. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 2004;(2): CD000515.PubMedGoogle Scholar
  124. 124.
    Bohner H, Friedrichs R, Habel U, et al. Delirium increases morbidity and length of stay after vascular surgery operations. Results of a prospective study [German]. Chirurg 2003;74:931–936.PubMedCrossRefGoogle Scholar
  125. 125.
    Moller JT, Cluitmans P, Rasmussen LS, et al. Longterm postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD Investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857–861.PubMedCrossRefGoogle Scholar
  126. 126.
    Monk TG, Saini V, Weldon BC, et al. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 2005;100:4–10.PubMedCrossRefGoogle Scholar
  127. 127.
    Weldon BC, Mahla ME, van der Aa MT, et al. Advancing age and deeper intraoperative anesthetic levels are associated with higher first year death rates. Anesthesiology 2002;97(Suppl):A1097.Google Scholar
  128. 128.
    Rasmussen LS, Johnson T, Kuipers HM, et al. ISPOCD2 (International Study of Postoperative Cognitive Dysfunction) Investigators. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand 2003;47:260–266.PubMedCrossRefGoogle Scholar
  129. 129.
    Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409–417.PubMedCrossRefGoogle Scholar
  130. 130.
    Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860–866.PubMedCrossRefGoogle Scholar
  131. 131.
    Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230–1236.PubMedCrossRefGoogle Scholar
  132. 132.
    Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg 1997;174:143–148.PubMedCrossRefGoogle Scholar
  133. 133.
    van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359–1367.PubMedCrossRefGoogle Scholar
  134. 134.
    Sander O, Welters ID, Foex P, et al. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 2005;33:81–88; discussion 241–242.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Leanne Groban
    • 1
  • Sylvia Y. Dolinski
    • 2
  1. 1.Department of AnesthesiologyWake Forest University School of MedicineWinston-SalemUSA
  2. 2.Department of Anesthesiology and Critical CareMedical College of WisconsinMilwaukeeUSA

Personalised recommendations